Evidence map›Paper›PMID 28545944›Full record

ArticleSchizophrenia research2018

Deviation from expected cognitive ability across psychotic disorders.

W C Hochberger, T Combs, J L Reilly, J R Bishop, R S E Keefe, B A Clementz, M S Keshavan, G D Pearlson, C A Tamminga, S K Hill and 1 more

Abstract read
In one paragraph

Article in Schizophrenia research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Brain structure, IQ, and psychopathology in young offspring of patients with schizophrenia or bipolar disorder.European psychiatry : the journal of the Association of European Psychiatrists · 2020
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 1 country.

W C HochbergerRosalind Franklin University of Medicine and Science, Department of Psychology, United States.
T CombsRosalind Franklin University of Medicine and Science, Department of Psychology, United States.
J L ReillyNorthwestern University, Department of Psychiatry and Behavioral Sciences, United States.
J R BishopUniversity of Minnesota, Department of Experimental and Clinical Pharmacology, Department of Psychiatry, United States.
R S E KeefeDuke University, Departments of Psychiatry, Neuroscience, and Psychology, United States.
B A ClementzUniversity of Georgia, Department of Psychology, United States.
M S KeshavanHarvard Medical School, Department of Psychiatry, United States.
G D PearlsonYale University School of Medicine, Department of Psychiatry, United States.
C A TammingaUT Southwestern Medical Center, Department of Psychiatry, United States.
S K HillRosalind Franklin University of Medicine and Science, Department of Psychology, United States. Electronic address: scot.hill@rosalindfranklin.edu.
J A SweeneyUniversity of Cincinnati, Department of Psychiatry and Behavioral Neuroscience, United States.
Rosalind Franklin University of Medicine and Science · USDuke University · USHarvard University · USNorthwestern University · USThe University of Texas Southwestern Medical Center · USUniversity of Cincinnati · USUniversity of Georgia · USUniversity of Minnesota · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Bipolar & Schizophrenia Consortium for Parsing Intermediate PhenotypesR01MH077851 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI TAMMINGA, CAROL A · 2007 to 2019
$7.8M
Bipolar & Schizophrenia Consortium for Parsing Intermediate PhenotypesR01MH077945 · NIMH · YALE UNIVERSITY · PI PEARLSON, GODFREY D · 2007 to 2019
$7.6M
Stability of Biotypes: a Longitudinal EvaluationR01MH078113 · NIMH · WAYNE STATE UNIVERSITY · PI KESHAVAN, MATCHERI S. · 2007 to 2019
$6.2M
Bipolar & Schizophrenia Consortium for Parsing Intermediate PhenotypesR01MH077852 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI THAKER, GUNVANT K · 2007 to 2010
$3.5M
Bipolar & Schizophrenia Consortium for Parsing Intermediate PhenotypesR01MH077862 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI SWEENEY, JOHN A · 2007 to 2010
$3.1M
Schizophrenia Pharmacogenetics: cognition and symptom response to antipsychoticsK08MH083888 · NIMH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BISHOP, JEFFREY R · 2009 to 2013
$899k
Enhancing Cognition in SchizophreniaK23MH072767 · NIMH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HILL, SCOT KRISTIAN · 2006 to 2010
$794k
NCATS NIH HHS UL1 TR001863NIMH NIH HHS K08 MH083888NIMH NIH HHS K23 MH072767NIMH NIH HHS R01 MH077851NIMH NIH HHS R01 MH077852NIMH NIH HHS R01 MH077862NIMH NIH HHS R01 MH077945NIMH NIH HHS R01 MH078113
6 · The paper itself

Abstract

Patients with schizophrenia show a deficit in cognitive ability compared to estimated premorbid and familial intellectual abilities. However, the degree to which this pattern holds across psychotic disorders and is familial is unclear. The present study examined deviation from expected cognitive level in schizophrenia, schizoaffective disorder, and psychotic bipolar disorder probands and their first-degree relatives. Using a norm-based regression approach, parental education and WRAT-IV Reading scores (both significant predictors of cognitive level in the healthy control group) were used to predict global neuropsychological function as measured by the composite score from the Brief Assessment of Cognition in Schizophrenia (BACS) test in probands and relatives. When compared to healthy control group, psychotic probands showed a significant gap between observed and predicted BACS composite scores and a greater likelihood of robust cognitive decline. This effect was not seen in unaffected relatives. While BACS and WRAT-IV Reading scores were themselves highly familial, the decline in cognitive function from expectation had lower estimates of familiality. Thus, illness-related factors such as epigenetic, treatment, or pathophysiological factors may be important causes of illness related decline in cognitive abilities across psychotic disorders. This is consistent with the markedly greater level of cognitive impairment seen in affected individuals compared to their unaffected family members.

Indexed as

FamilyAdultCognition DisordersFemaleHumansMaleMiddle AgedNeuropsychological TestsPredictive Value of TestsPsychiatric Status Rating ScalesPsychotic DisordersRecognition, PsychologyStatistics, NonparametricYoung AdultBrief assessment of cognition in schizophreniaCognitive declineFirst-degree relativesPremorbid cognitionPsychotic disorders

Identifiers

PMID28545944
PMCPMC5699979
OpenAlexW2620099622

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.